Resultados de la búsqueda 161-170 de 3705 para anti-TNF drugs
... Anti-Platelet) agents. In addition to exploring ED treatment patterns and success of both ischemic and bleeding risk stratification prior to definition of ...
This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric and ...
After enrollment, patients will receive one cycle of Induction chemotherapy. Subsequent therapy will be based upon MIBG avidity and ALK status. Patients with ...
Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous ...
Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them ...
... Anti-PD-1/L1 in Patients with Locally Advanced or ... treatment in patients with treatment-naive ALK-positive advanced NSCLC. ... treatment until disease ...
... treatment, while rates of disease control during Induction have not improved ... therapy with 131I-MIBG or the ALK inhibitor, crizotinib. After ...
... therapy/side-effects-hormone-therapy. Accessed Jan. 11, 2023. Noe JF, et al. Endocrine therapy for breast cancer. The Journal for Nurse Practitioners. 2021 ...
This trial also studies the outcomes of patients with mixed phenotype acute leukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?